Ex vivo expansion of haemopoietic progenitor cells

Blood Reviews

Volumn 10, Issue 3, 1996, Pages 167-176

  Alcorn, M J ^a   Holyoake, T L ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEMOPOIETIC GROWTH FACTOR;

CELL CULTURE; CELL PROLIFERATION; CELL TRANSPLANTATION; GENE THERAPY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STROMA CELL;

EID: 0029804275     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90023-5     Document Type: Article

References (80)

1. Tavassoli M. Bone marrow: the seedbed of blood. In: Wintrobe MM, ed. Blood, Pure and Eloquent. New York: McGraw Hill, 1980: 57-79.
2. Freshney RI, Pragnell IB, Freshney MG. Culture of Hematopoietic Cells. New York: Wiley-Liss, 1994.
3. Callard RE, Gearing AJH, eds. The Cytokine FactsBook. London: Academic Press, 1994.
4. Yao Z, Painter SL, Fanslow WC et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483-5486.
5. Holyoake TL, Alcorn MJ. CD34 positive haemopoietic cells: biology and clinical applications. Blood Rev 1994; 8: 113-124.
6. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157-165.
7. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1989; 86: 8897-8901.
8. De Vries P, Brasel KA, Eisenman JR et al. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 1991; 173: 1205-1211.
9. Luskey BD, Rosenblatt M, Zsebo K, Williams DA. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 1992; 80: 396-402.
10. d mice as a single factor. Blood 1992; 79: 913-919.
11. Muench MO, Schneider JG, Moore MAS. Interactions among colony-stimulating factors, IL-1β, IL-6 and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 1992; 20: 339-349.
12. Neben S, Donaldson D, Sieff C et al. Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp Hematol 1994; 22: 353-359.
13. Ploemacher RE, van Soest PL, Voorwinden H, Boudewijn A. Interleukin-12 synergises with interleukin-3 and steel factor to enhance recovery of murine hematopoietic stem cells in liquid culture. Leukemia 1993; 7: 1381-1388.
14. Muench MO, Moore MAS. Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors. Exp Hematol 1992; 20: 611-618.
15. Muench MO, Firpo MT, Moore MAS. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 1993; 81: 3463-3473.
16. Serrano F, Varas F, Bernad A, Bueren JA. Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplantation 1994; 14: 855-862.
17. Holyoake TL, Freshney MG, McNair L et al. Ex vivo expansion with SCF and IL-11 augments both short term recovery post-transplant and the ability to serially transplant marrow. Blood 1996; 87: 4589-4595.
18. + cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 1994; 83: 128-136.
19. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
20. + hematopoietic progenitor cells: implications for the expansion of contaminating tumor cells. Exp Hematol 1995; 23(8): 845a.
21. + progenitor cells. Blood 1995; 86 (Suppl. 1): 295a.
22. + cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 1687-1691.
23. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101-110.
24. + cells. Blood 1994; 84: 2930-2939.
25. + cells from patients with stage IV breast cancer. Blood 1994; 84: 3567-3574.
26. Schwartz R, Emerson SG, Clarke MF, Palsson BO. In vitro myelopoiesis stimulated by rapid medium exchange and supplementation with hematopoietic growth factors. Blood 1991; 78: 3155-3161.
27. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion culture. Blood 1993; 82: 378-384.
28. Lu L, Xiao M, Grisby S et al. Comparative effects of suppressive cytokines on isolated single CD34+++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol 1993; 21: 1442-1446.
29. Westwood NB, Chung R, Emmerson JB, Pearson TC. The in vitro effects of stem cell factor, interleukin 3 and granulocyte-macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants. Br J Haematol 1994; 86: 468-474.
30. Traycoff CM, Kosak ST, Grigsby S, Srour EF. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 1995; 85: 2059-2068.
31. + cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions. Br J Haematol 1994; 86: 461-467.
32. + human fetal liver progenitors with a high proliferative potential. Blood 1994; 83: 3170-3181.
33. Traycoff CM, Abboud MR, Laver J et al. Evaluation of the in vitro behaviour of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994; 22: 215-222.
34. Harley CB, Futcher AB, Greider CW Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
35. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp P. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
36. Brandt JE, Bhalla K, Hoffman R. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 1994; 83: 1507-1514.
37. Verfaillie CM, Catanzarro PM, Li W. Macrophage inflammatory protein 1a, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 1994; 179: 643-649.
38. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93: 1470-1474.
39. Shah AJ, Smogorzewska EM, Hannum C, Crooks GM. Flt3 ligand (FL) is a potent inducer of proliferation of highly quiescent human bone marrow CD34+CD38- cells. Blood 1995; 86 (Suppl 1): 423a.
40. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082-3088.
41. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Eng J Med 1995; 333: 283-287.
42. Alcorn MJ, Holyoake TL, Richmond L et al. CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996; 14: 1839-1847.
43. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 1992; 79: 634-641.
44. + cells into the myeloid lineage. Blood 1992; 80: 1405-1412.
45. Leary AG, Ikebuchi K, Hirai Y et al. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1a. Blood 1988; 71: 1759-1763.
46. Brandt J, Baird N, Lu L, Srour E, Hoffman R. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 1988; 82: 1017-1027.
47. + progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, interferon-γ, and erythropoietin. Blood 1993; 81: 2579-2584.
48. + cells. Blood 1993; 82: 3600-3609.
49. + hematopoietic progenitors. In: Gee AP, Gross S, Worthington-White DA, eds. Advances in Bone Marrow Purging and Processing. Fourth International Symposium. New York: Wiley-Liss, 1994: 217-228.
50. Alcorn MJ, Holyoake TL, Richmond LJ et al. Improved ex vivo expansion of CD34 selected PBPC using high expansion culture bags. Br J Haematol 1996; 93 (Suppl 1): 42a.
51. + cells isolated from cryopreserved mobilised peripheral blood progenitor cells (PBPC). Exp Hematol 1995; 23 (8): 909a.
52. Szilvassy SJ, Humphries RK, Lansdorp PM, Eaves AC, Eaves CJ. Quantitative assay for totipotent reconstituting hemopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci USA 1990; 87: 8736-8740.
53. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 1993; 81: 661-669.
54. Verfaillie CM. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993; 82: 2045-2053.
55. Rosnet O, Schiff C, Pebusque M-J et al. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 82: 1110-1119.
56. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91: 459-463.
57. Lyman SD, James L, Johnson L et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83: 2795-2801.
58. Hannum CH, Culpepper J, Campbell D et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates the growth response of haematopoietic stem cells and is encoded by variant mRNAs. Nature 1994; 368: 643-648.
59. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD. Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp Hematol 1995; 23: 1121-1129.
60. + bone marrow progenitor cells in vitro. Blood 1996; 87: 1317-1325.
61. + CD38 human marrow cells. Blood 1995; 86 (Suppl 1): 493a.
62. Verfaillie CM, McGlave P. Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic cells. Blood 1991; 77: 263-270.
63. + cells purified from cord blood and fetal liver. Exp Hematol 1995; 23: 422-427.
64. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335-344.
65. Coutinho LH, Will A, Radford J, Schiro R, Testa NY, Dexter TM. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood 1990; 75: 2118-2129.
66. Lemoli RM, Tafuri A, Strife A, Andreeff M, Clarkson BD, Gulati SC. Proliferation of human hematopopietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. Exp Hematol 1992; 20: 569-575.
67. Koller MR, Palsson MA, Manchel I, Palsson BO. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 1995; 86: 1784-1793.
68. Zandstra PW, Eaves CJ, Cameron G, Piret JM. Cytokine depletion in long-term stirred suspension cultures of normal human marrow. J Hematotherapy 1995; 4: 235a.
69. Gupta P, McCarthy JB, Verfaillie CM. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 1996; 87: 3229-3236.
70. - cells is possible in a clinically suitable stroma conditioned medium culture supplemented with one or two cytokines. Blood 1995; 86 (Suppl 1): 294a.
71. Silver SM, Adams PT, Hutchinson RJ et al. Phase I evaluation of ex vivo expanded hematopoietic cells produced by perfusion cultures in autologous bone marrow transplantation (BMT). Blood 1993; 82 (Suppl 1): 297a.
72. Champlin R, Mehra R, Gajewski J et al. Ex vivo expanded progenitor cell transplantation in patients with breast cancer. Blood 1995; 86 (Suppl 1): 295a.
73. Holyoake TL, Alcorn MJ, Richmond L et al. A phase I study to evaluate the safety of re-infusing CD34 cells expanded ex vivo as part or all of a PBPC transplant procedure. Blood 1995; 86 (Suppl 1): 294a.
74. + blood progenitors for anticancer therapy. Exp Hematol 1995; 23: 1463-1471.
75. + hematopoietic progenitor cells. Blood 1996; 87: 1292-1302.
76. + hematopoietic progenitor cells. Blood 1995; 85: 3538-3546.
77. Silva MRG, Parreira A, Ascensao JL. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion. Exp Hematol 1995; 23: 1676-1681.
78. + cells mobilized by granulocyte colony-stimulating factor. Br J Haematol 1996; 92: 788-794.
79. Schattner M, Lefebvre P, Spanier S et al. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells 1996; 14: 207-214.
80. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.